Chemoinformaics analysis of 1,2-DIMETHOXYXANTHEN-9-ONE
| Molecular Weight | 256.257 | nRot | 2 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 17 |
| Exact Molecular Weight | 256.074 | nRing | 3 |
| Solubility: LogS | -3.77 | nHRing | 1 |
| Solubility: LogP | 2.906 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 36.2595 |
| nHD | 0 | BPOL | 18.1145 |
| QED | 0.661 |
| Synth | 1.967 |
| Natural Product Likeliness | 0.605 |
| NR-PPAR-gamma | 0.295 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.948 |
| Pgp-sub | 0.025 |
| HIA | 0.003 |
| CACO-2 | -4.683 |
| MDCK | 0.0000324 |
| BBB | 0.233 |
| PPB | 0.872451 |
| VDSS | 0.729 |
| FU | 0.118237 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.974 |
| CYP2c19-inh | 0.909 |
| CYP2c19-sub | 0.71 |
| CYP2c9-inh | 0.674 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.435 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.528 |
| CL | 2.86 |
| T12 | 0.316 |
| hERG | 0.217 |
| Ames | 0.79 |
| ROA | 0.186 |
| SkinSen | 0.682 |
| Carcinogencity | 0.881 |
| EI | 0.95 |
| Respiratory | 0.343 |
| NR-Aromatase | 0.628 |
| Antiviral | Yes |
| Prediction | 0.650373 |